Respiratory & ENT
Research-Grade RWD in Respiratory & ENT
Exclusive Partnership
AAO-HNSF + OM1
The American Academy of Otolaryngology and Head and Neck Surgery Foundation (AAO-HNSF) Reg-ENT registry collects data on ENT conditions and their treatments. Together, OM1 and AAO-HNSF have partnered to deliver access to the largest, most representative respiratory and ENT data network available for research, analytics, and collaboration.
- 3,000 clinicians
- 500 practices
- >25 Million patient visits
Deep Clinical Data
Across ENT Conditions
Access structured EMR, unstructured data (such as clinician notes), and imaging. Collect additional data, including patient reported outcomes (PROs), such as SNOT 22.
- Allergy
- Asthma
- Chronic rhinosinusities (CRS) & nasal polyps
- COPD
- Head and neck cancer
- Hearing loss
- Sleep apnea
Research & Analytics
Sample Use Cases
The ENT data network can be used for conducting studies, analysis, modeling, and more.
- Analyze treatment comparative effectiveness
- Recruit patients for clinical trials
- Create external control arms
- Explore treatment gaps
- Conduct FDA studies
- Gain market intelligence
- Understand and track device usage
- Find rare disease patients
- Predict which patients are likely to benefit or have higher risks
Why OM1 ENT?
AAO-HNSF & OM1 Partnership
Publications
Real-world evidence analysis of the impact of steroid-eluting implants on healthcare resource use among chronic rhinosinusitis patients undergoing sinus surgery, Current Medical Research and Opinion, January 2022,
Meet our ENT expert
Dr. Richard Gliklich, MD is the CEO of OM1, Inc. Previously, he was founder and CEO of Outcome, which he led from inception through its acquisition by Quintiles.
Dr. Gliklich is well known in the areas of registries, outcomes and analytics. He is senior editor of the landmark publication by the U.S. Agency for Healthcare Research and Quality (AHRQ) handbook “Registries for Evaluating Patient Outcomes: A User’s Guide” and the PI for the Outcomes Measures Framework, which focuses on standardization of outcomes measurement. He has led several key national and international efforts focused on evaluating the safety, effectiveness, value and quality of healthcare. Dr. Gliklich also holds several patents for both health outcomes systems and medical devices.
Dr. Gliklich is a graduate of Yale University and Harvard Medical School and a former Charles A. Dana Scholar at the University of Pennsylvania. He is also a surgeon and the Leffenfeld Professor at Harvard Medical School.